5 More Unloved Growth Stocks

Ah, skepticism, how I love thee.

We rebel investors at Motley Fool Rule Breakers believe the multibaggers in the making, while not often cheap by the numbers, are always misunderstood. As such, they face extraordinary skepticism, which, in turn, makes them excellent value stocks.

More are out there. Each week, right here in this column, we'll hunt them down. Grab your keyboard.

What one stock can do for you
Really, it's worth your time. One home run stock can make all the difference to your portfolio.

Just ask David Gardner, captain of the good pirate ship Rule Breakers, who bought AOL in 1994. Today, in the form of shares of Time Warner (NYSE:TWX), that investment has brought him a 4,582% gain.

That helped him to overcome stinging losses from Celera Genomics, Sirius Satellite Radio, and others to put up nine years of better than 20% average annual returns as the leader of the real-money Rule Breaker portfolio.

Let the haters be your friends
Today, David and his team still seek misunderstood growers. You can, too, with the help of our completely free-of-charge Motley Fool CAPS investor-intelligence database, which contains information on more than 4,600 stocks.

CAPS applies user input to rate stocks from one star (low) to five (high). Using CAPS, we're going to search for one- and two-star stocks that have at least 5% of their available shares sold short but are expected to grow their earnings by no less than 15% over each of the next five years.

Let's have the list
Now, with that preamble behind us, here are five unloved growth stocks:

Bear in mind that this isn't a list of recommendations. Instead, I offer these stocks as candidates for further research. But of these five, it's health-care tech provider Omnicell that interests me most.

That's not an easy call to make, believe me. Omnicell just pushed through a pricey secondary offering, which will dilute existing owners' shares. But I sense that dilution will be more than outweighed by heavy growth. A 0.90 PEG ratio suggests I'm right, as do Omnicell's steadily rising returns on capital.

Intrigued? Do your own due diligence and then check in with thousands of other investors at CAPS. And, if you'd like, add your own commentary. You'll be helping your fellow Fools and testing your ideas at the same time. Click here to get started now; the service is 100% free.

See you back here next week for five more unloved growth stocks.

Openwave is an active Rule Breakers recommendation. Get a month of free access to the entire market-beating portfolio, which features seven stocks that have at least doubled. There's no obligation to subscribe.

Time Warner is a Stock Advisor pick.

Fool contributor Tim Beyers, who is ranked 6,373 out of more than 30,200 rated investors in CAPS, is a sucker for growth stocks and a regular contributor to Rule Breakers. Tim didn't own shares in any of the companies mentioned in this article at the time of publication. His holdings can be found at his Fool profile. His thoughts on growth stocks, Foolishness, and investing in general may be found in his blog. The Motley Fool's disclosure policy is your portfolio's competitive advantage.